https://idataresearch.com/wp-content/themes/lambda-child-theme/images/footer-logo.png
https://idataresearch.com/wp-content/themes/lambda-child-theme/images/idata-white-logo.png

Leads

Showing all 4 results

Cardiac Rhythm Management Market Analysis, Size, Trends | Global | 2019-2025 | MedSuite | Includes: Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy Devices, and 5 more

Global Cardiac Rhythm Management Industry Trends Overall, the global cardiac rhythm management, electrophysiology and cardiac ablation market was valued at $15 billion in 2018. This is expected to increase over the forecast period at a CAGR of 4.2% to reach $20.1 billion by 2025. Currently, the majority of the global market share is controlled by

more...

Cardiac Rhythm Management Market Analysis, Size, Trends | United States | 2019-2025 | MedSuite | Includes: Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy Devices, and 5 more

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the

more...

Cardiac Rhythm Management Market Analysis, Size, Trends | Europe | 2019-2025 | MedSuite | Includes: Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy Devices, and 5 more

The total market for Europe’s cardiac rhythm management devices market is growing at a rate of 3.9%, which will take the 2018 market value of €2.2 billion up to €2.9 billion by 2025. Reprocessed diagnostic electrophysiology (EP) catheters accounted for a significant percentage of all diagnostic EP catheters used. Reprocessed catheters have a much lower

more...

Cardiac Leads Market Size, Share, Trends & Analysis | Global | 2019-2025 | MedCore | Segmented by: Type (Pacing Lead, Defibrillation Lead & LV Lead)

The global cardiac leads market size is expected to reach over $2,197 million by 2025, with the left ventricular (LV) lead market segment showing the highest growth. The majority of the global cardiac leads market share was controlled by Medtronic, Abbott, and Boston Scientific. Overall, this global market research includes an analysis of cardiac leads companies spawning across more than 70 countries in the world.

more...